MPs react to drug firm’s change of heart: Apotex withdraws $25m in research funds
The country's largest generic drug company is withdrawing millions of dollars in research and hospital donations and placing the blame on recently passed government patent drug regulations.
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy












